Literature DB >> 9626992

Synergistic neurotoxic effects of combined treatments with cytokines in murine primary mixed neuron/glia cultures.

G H Jeohn1, L Y Kong, B Wilson, P Hudson, J S Hong.   

Abstract

Activation of brain glial cells with the bacterial endotoxin lipopolysaccharide (LPS), the HIV-1 coat protein gp120, or beta-amyloid-derived peptides, stimulates the expression of several cytokines, including tumor necrosis factor-alpha (TNFalpha), interleukin-1 (IL-1) and IL-6. and nitric oxide (NO) which have been proposed as causes of neurodegeneration in the brain. In the present study, the neurotoxic effects of several cytokines, alone or in various combinations, and the correlations of the release of lactate dehydrogenase, the loss of neurons, and the secretion of NO in brain neuronal cell injury were investigated in murine primary mixed neuronal/glial cell cultures. A specific combination of cytokines, i.e., IL-1 (1 ng/ml)+ TNFalpha (10 ng/ml)/interferon-gamma (IFNgamma) (200 u/ml), induced a dramatic neuronal cell injury in the neuron/glia cultures, and its cytotoxic profile was very similar to that seen with the LPS/IFNgamma-induced neuron injury. This indicates that among the many toxic immune mediators secreted in response to LPS, IL-1 and TNFalpha can mimic LPS as the triggering signals and primary mediators for glia-mediated neuron injury in the presence of IFNgamma. This study provides new insights about the cytotoxic mechanism(s) for cytokine-mediated neuron injury.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9626992     DOI: 10.1016/s0165-5728(97)00204-x

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  32 in total

Review 1.  Mechanisms of tumor necrosis factor alpha action on neurodegeneration: interaction with insulin-like growth factor-1.

Authors:  S A Loddick; N J Rothwell
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-17       Impact factor: 11.205

Review 2.  Cytokine/neurotrophin interaction in the aged central nervous system.

Authors:  N J Macdonald; F Decorti; T C Pappas; G Taglialatela
Journal:  J Anat       Date:  2000-11       Impact factor: 2.610

3.  Distinct role for microglia in rotenone-induced degeneration of dopaminergic neurons.

Authors:  Hui-Ming Gao; Jau-Shyong Hong; Wanqin Zhang; Bin Liu
Journal:  J Neurosci       Date:  2002-02-01       Impact factor: 6.167

4.  Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia.

Authors:  W G Kim; R P Mohney; B Wilson; G H Jeohn; B Liu; J S Hong
Journal:  J Neurosci       Date:  2000-08-15       Impact factor: 6.167

5.  Salmonella lipopolysaccharide (LPS) mediated neurodegeneration in hippocampal slice cultures.

Authors:  Sara Johansson; Svante Bohman; Ann-Cathrin Radesäter; Caroline Oberg; Johan Luthman
Journal:  Neurotox Res       Date:  2005-11       Impact factor: 3.911

Review 6.  'Evolutionary medicine' perspectives on Alzheimer's Disease: Review and new directions.

Authors:  Molly Fox
Journal:  Ageing Res Rev       Date:  2018-07-27       Impact factor: 10.895

7.  The brain expression of genes involved in inflammatory response, the ribosome, and learning and memory is altered by centrally injected lipopolysaccharide in mice.

Authors:  R H Bonow; S Aïd; Y Zhang; K G Becker; F Bosetti
Journal:  Pharmacogenomics J       Date:  2008-10-28       Impact factor: 3.550

Review 8.  Integration of cytokine biology and lipid metabolism in stroke.

Authors:  Rao Muralikrishna Adibhatla; Robert Dempsy; James Franklin Hatcher
Journal:  Front Biosci       Date:  2008-01-01

Review 9.  Role of the immune system in the pathogenesis, prevention and treatment of Alzheimer's disease.

Authors:  Imrich Blasko; Beatrix Grubeck-Loebenstein
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

Review 10.  Ceramide and neurodegeneration: susceptibility of neurons and oligodendrocytes to cell damage and death.

Authors:  Arundhati Jana; Edward L Hogan; Kalipada Pahan
Journal:  J Neurol Sci       Date:  2009-01-14       Impact factor: 3.181

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.